Is Interleukin-6 blockade a viable strategy to prevent progression of acute respiratory distress syndrome in non-COVID viral pneumonia?
Clin Immunol Commun
.
2023 Dec:3:21-22.
doi: 10.1016/j.clicom.2023.02.004.
Epub 2023 Feb 10.
Authors
Rana Prathap Padappayil
1
,
Siva Naga S Yarrarapu
1
,
Raghu Tiperneni
1
,
Boning Li
2
Affiliations
1
Internal Medicine, Monmouth Medical Center, United States.
2
Pulmonary and Critical Care Medicine, Monmouth Medical Center, United States.
PMID:
38014402
PMCID:
PMC9912812
DOI:
10.1016/j.clicom.2023.02.004
No abstract available